These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1006 related articles for article (PubMed ID: 15448006)
1. Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients. Dulaimi E; Hillinck J; Ibanez de Caceres I; Al-Saleem T; Cairns P Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6189-93. PubMed ID: 15448006 [TBL] [Abstract][Full Text] [Related]
2. Epigenetic alterations by methylation of RASSF1A and DAPK1 promoter sequences in mammary carcinoma detected in extracellular tumor DNA. Ahmed IA; Pusch CM; Hamed T; Rashad H; Idris A; El-Fadle AA; Blin N Cancer Genet Cytogenet; 2010 Jun; 199(2):96-100. PubMed ID: 20471512 [TBL] [Abstract][Full Text] [Related]
3. Tumor cell-specific BRCA1 and RASSF1A hypermethylation in serum, plasma, and peritoneal fluid from ovarian cancer patients. Ibanez de Caceres I; Battagli C; Esteller M; Herman JG; Dulaimi E; Edelson MI; Bergman C; Ehya H; Eisenberg BL; Cairns P Cancer Res; 2004 Sep; 64(18):6476-81. PubMed ID: 15374957 [TBL] [Abstract][Full Text] [Related]
4. [Detection and significance of APC gene promoter hypermethylation in serum of breast cancer patients]. Zhang JJ; Ouyang T; Wan WH; Xu GW; Deng GR Ai Zheng; 2007 Jan; 26(1):44-7. PubMed ID: 17222366 [TBL] [Abstract][Full Text] [Related]
5. Distinct hypermethylation profile of primary breast cancer is associated with sentinel lymph node metastasis. Shinozaki M; Hoon DS; Giuliano AE; Hansen NM; Wang HJ; Turner R; Taback B Clin Cancer Res; 2005 Mar; 11(6):2156-62. PubMed ID: 15788661 [TBL] [Abstract][Full Text] [Related]
6. Promoter hypermethylation of tumor suppressor genes in urine from kidney cancer patients. Battagli C; Uzzo RG; Dulaimi E; Ibanez de Caceres I; Krassenstein R; Al-Saleem T; Greenberg RE; Cairns P Cancer Res; 2003 Dec; 63(24):8695-9. PubMed ID: 14695183 [TBL] [Abstract][Full Text] [Related]
7. Detection of RASSF1A aberrant promoter hypermethylation in sputum from chronic smokers and ductal carcinoma in situ from breast cancer patients. Honorio S; Agathanggelou A; Schuermann M; Pankow W; Viacava P; Maher ER; Latif F Oncogene; 2003 Jan; 22(1):147-50. PubMed ID: 12527916 [TBL] [Abstract][Full Text] [Related]
8. Aberrant promoter hypermethylation in serum DNA from patients with silicosis. Umemura S; Fujimoto N; Hiraki A; Gemba K; Takigawa N; Fujiwara K; Fujii M; Umemura H; Satoh M; Tabata M; Ueoka H; Kiura K; Kishimoto T; Tanimoto M Carcinogenesis; 2008 Sep; 29(9):1845-9. PubMed ID: 18632757 [TBL] [Abstract][Full Text] [Related]
9. Aberrant promoter methylation in bronchial epithelium and sputum from current and former smokers. Belinsky SA; Palmisano WA; Gilliland FD; Crooks LA; Divine KK; Winters SA; Grimes MJ; Harms HJ; Tellez CS; Smith TM; Moots PP; Lechner JF; Stidley CA; Crowell RE Cancer Res; 2002 Apr; 62(8):2370-7. PubMed ID: 11956099 [TBL] [Abstract][Full Text] [Related]
11. Promoter hypermethylation of the death-associated protein kinase gene in breast cancer is associated with the invasive lobular subtype. Lehmann U; Celikkaya G; Hasemeier B; Länger F; Kreipe H Cancer Res; 2002 Nov; 62(22):6634-8. PubMed ID: 12438260 [TBL] [Abstract][Full Text] [Related]
12. Quantitative detection of promoter hypermethylation of multiple genes in the tumor, urine, and serum DNA of patients with renal cancer. Hoque MO; Begum S; Topaloglu O; Jeronimo C; Mambo E; Westra WH; Califano JA; Sidransky D Cancer Res; 2004 Aug; 64(15):5511-7. PubMed ID: 15289362 [TBL] [Abstract][Full Text] [Related]
13. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions. Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681 [TBL] [Abstract][Full Text] [Related]
14. [Detection of free tumor-related DNA in the serum of breast cancer patients]. Zhang JJ; Ouyang T; Wan WH; Deng GR Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):609-13. PubMed ID: 18210882 [TBL] [Abstract][Full Text] [Related]
15. Promoter hypermethylation profile of ovarian epithelial neoplasms. Makarla PB; Saboorian MH; Ashfaq R; Toyooka KO; Toyooka S; Minna JD; Gazdar AF; Schorge JO Clin Cancer Res; 2005 Aug; 11(15):5365-9. PubMed ID: 16061849 [TBL] [Abstract][Full Text] [Related]
16. Frequent death-associated protein-kinase promoter hypermethylation in brain metastases of solid tumors. Gonzalez-Gomez P; Bello MJ; Alonso ME; Lomas J; Arjona D; Amiñoso C; De Campos JM; Isla A; Gutierrez M; Rey JA Oncol Rep; 2003; 10(4):1031-3. PubMed ID: 12792765 [TBL] [Abstract][Full Text] [Related]
17. Promoter hypermethylation of TMS1, BRCA1, ERalpha and PRB in serum and tumor DNA of invasive ductal breast carcinoma patients. Mirza S; Sharma G; Prasad CP; Parshad R; Srivastava A; Gupta SD; Ralhan R Life Sci; 2007 Jul; 81(4):280-7. PubMed ID: 17599361 [TBL] [Abstract][Full Text] [Related]
18. Promoter hypermethylation patterns of p16, O6-methylguanine-DNA-methyltransferase, and death-associated protein kinase in tumors and saliva of head and neck cancer patients. Rosas SL; Koch W; da Costa Carvalho MG; Wu L; Califano J; Westra W; Jen J; Sidransky D Cancer Res; 2001 Feb; 61(3):939-42. PubMed ID: 11221887 [TBL] [Abstract][Full Text] [Related]
19. Detection of gene promoter hypermethylation in the tumor and serum of patients with gastric carcinoma. Lee TL; Leung WK; Chan MW; Ng EK; Tong JH; Lo KW; Chung SC; Sung JJ; To KF Clin Cancer Res; 2002 Jun; 8(6):1761-6. PubMed ID: 12060614 [TBL] [Abstract][Full Text] [Related]
20. Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients. Sharma G; Mirza S; Parshad R; Srivastava A; Gupta SD; Pandya P; Ralhan R Life Sci; 2010 Jul; 87(3-4):83-91. PubMed ID: 20470789 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]